BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 676122)

  • 1. [Humoral factors in cardiogenic shock].
    Kölbel F; Veselý P
    Vnitr Lek; 1978 Jul; 24(7):657-60. PubMed ID: 676122
    [No Abstract]   [Full Text] [Related]  

  • 2. [Negative inotropic effect of humoral plasma factors in cardiogenic shock].
    Hennig E; Senges J; Brachmann J; Pelzer D; Wieland H; Mehmel HC; Mäurer W; Kübler W
    Verh Dtsch Ges Inn Med; 1978; (84):1521-3. PubMed ID: 742004
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial: Myocardial depressant factor (MDF) in cardiogenic shock.
    Vaisrub S
    JAMA; 1974 Apr; 228(4):500. PubMed ID: 4406217
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current status of the myocardial depressant factor (MDF) and shock].
    Favaro R; Pelaia P
    Minerva Anestesiol; 1979; 45(7-8):594-600. PubMed ID: 548819
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serial changes in myocardial depressant factor (Lefer) activities in cardiogenic shock].
    Okuda N; Yamada T; Hashizume T; Hosono K
    Rinsho Byori; 1974 Oct; 22(10 Suppl):6. PubMed ID: 4475976
    [No Abstract]   [Full Text] [Related]  

  • 6. B-type natriuretic peptide and its molecular precursor in myocardial infarction complicated by cardiogenic shock.
    Hejmdal A; Boesgaard S; Lindholm MG; Goetze JP
    J Card Fail; 2007 Apr; 13(3):184-8. PubMed ID: 17448415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of adrenal cortex hormone in endotoxic shock, with special reference to its effect on cardiac function and myocardial depressant factor].
    Kosugi I; Yamaguchi Y; Kawaguchi T; Kawashima Y; Okada K
    Masui; 1976 Feb; 25(2):171-8. PubMed ID: 943602
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: Myocardial depressant factor in cardiogenic shock.
    Wangensteen SL; Crampton RS; Ferguson WW
    JAMA; 1974 Jun; 228(13):1638-9. PubMed ID: 4406660
    [No Abstract]   [Full Text] [Related]  

  • 9. [Controversial problems of the pathogenesis of cardiogenic shock in myocardial infarct].
    Moiseev SG
    Klin Med (Mosk); 1973 Dec; 51(12):14-9. PubMed ID: 4591755
    [No Abstract]   [Full Text] [Related]  

  • 10. [Metabolic shifts in shock during the acute period of myocardial infarct].
    Kleĭman BI
    Klin Med (Mosk); 1972 May; 50(5):38-44. PubMed ID: 5048407
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cardiogenic shock in acute myocardial infarct].
    Malík J; Murín J; Kasper J; Mikla F
    Vnitr Lek; 1997 Jun; 43(6):366-8. PubMed ID: 9601866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the myocardial depressant factor and its relative influence in drug/alcohol mortality.
    Manning TJ; Williams LE; Lynch VD; Bidanset JH; Drake W; Lukash L
    J Forensic Sci; 1980 Jul; 25(3):550-63. PubMed ID: 7400768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A low-molecular blood serum factor suppressing myocardial function in traumatic shock complicated by massive blood loss].
    Antonenko VT; Treshchinskiĭ AI; Korolev IuN; Shlapak IP
    Anesteziol Reanimatol; 1988; (5):42-4. PubMed ID: 3218778
    [No Abstract]   [Full Text] [Related]  

  • 14. [Humoral regulation of microcircultation in myocardial infarct and cardiogenic shock].
    Malaia LT; Vlasenko MA; Mikliaev IIu; Kravchun PG
    Vestn Akad Med Nauk SSSR; 1977; (1):79-90. PubMed ID: 842142
    [No Abstract]   [Full Text] [Related]  

  • 15. High plasma N-terminal pro-brain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shock.
    Vergès B; Zeller M; Desgrès J; Dentan G; Laurent Y; Janin-Manificat L; L'Huillier I; Rioufol G; Beer JC; Makki H; Rochette L; Gambert P; Cottin Y
    Eur Heart J; 2005 Sep; 26(17):1734-41. PubMed ID: 15831555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiogenic shock in acute myocardial infarction--what we know in 2005].
    Vojácek J; Bis J
    Cas Lek Cesk; 2005; 144 Suppl 3():30-2. PubMed ID: 16335260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiogenic shock in acute myocardial infarction.
    Ashby DT; Stone GW; Moses JW
    Catheter Cardiovasc Interv; 2003 May; 59(1):34-43. PubMed ID: 12720238
    [No Abstract]   [Full Text] [Related]  

  • 18. Release of myocardial depressant factor (MDF) during cardiopulmonary bypass (CPB): influence of corticosteroids (methylprednisolone) and protease inhibitor (aprotinin).
    Coraim FI; Laufer G; Ilias W; Wollenek G; Wolner E
    Prog Clin Biol Res; 1987; 236A():611-20. PubMed ID: 2441410
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome: a report from the SHOCK Trial Registry].
    Matos VA;
    Rev Port Cardiol; 2001 Mar; 20(3):349-50. PubMed ID: 11421242
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cardiogenic shock in the course of myocardial infarction (author's transl)].
    Perret CL; Enrico JF; Rivier E; Verdon F
    Ther Umsch; 1976 Feb; 33(2):109-14. PubMed ID: 960040
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.